The HIV pandemic has affected over 2.3 million people in the World Health Organization’s (WHO) European Region, with nearly 300 new diagnoses made daily in 2021. The COVID-19 pandemic and geopolitical turbulences in the region impacted the course of the HIV pandemic and the response, displacing populations, and disrupting access to care and HIV testing. […] Continue reading ->
Regional vaccine production features in the draft pandemic accord, but there is still a long road before this becomes a reality Aspen Pharmacare invested millions of dollars in scaling up its South African production plant to make COVID-19 vaccines – yet it never sold a single vial. Meanwhile, in a “demoralising blow”, Bangladesh’s government rejected […] Continue reading ->
The World Health Organization (WHO) has ended the global health emergency for mpox, marking the end of a 10-month juggling act by the UN health agency as it scrambled to deal with concurrent global pandemics.  The announcement arrives just days after WHO declared the end of the global health emergency for COVID-19 last Friday, three […] Continue reading ->
The United Nations (UN) is hosting three multi-stakeholder meetings in New York on Monday and Tuesday on tuberculosis, pandemic prevention, preparedness and response (PPPR) and universal health coverage (UHC). They are aimed at getting the views of non-state actors in preparation for UN High-Level meetings in September, starting with pandemic preparedness on 20 September, followed […] Continue reading ->
Barriers to inclusive health are spurring African innovators into action. But to build an inclusive health system the continent needs to address structural inequalities – political, social and economic – and this will require that private and public partners alike embrace radical collaboration to support inclusive innovation. When public health graduate student, Jason Carmichael, arrived […] Continue reading ->
The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading ->
The conspiracy-based anti-science attacks on scientists and vaccines that proliferated during the COVID-19 pandemic in the US are likely to have chilling, long-term effects on biomedicine, according to Professor Peter Hotez, Dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston.  The biggest casualty may be childhood vaccinations, leading to […] Continue reading ->